Q32 Bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Q32 Bio generated cash of -$96,230,000, which is less than the previous year. Cash used in financing activities reached the amount of $184,000 last year. Net change in cash is therefore $5,280,000.
Cash Flow
| 2017 | 6.47M | -81.52M | 115.22M |
|---|---|---|---|
| 2019 | -91.35M | -51.79M | 158.21M |
| 2020 | -94.33M | 204.89M | 53.09M |
| 2021 | -32.97M | -157K | 20.10M |
| 2022 | -10.95M | -2.46M | 30.06M |
| 2023 | -96.23M | 101.32M | 184K |
QTTB Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 33.98M | 32.89M | 45.92M | 53.77M | 38.22M | 11.39M |
Operating activities | ||||||
Net income | -112.96M | -42.80M | -37.56M | -128.69M | -103.91M | -29.99M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 578K | 370K | 47K | 8.90M | 6.31M | 684.21K |
Stock-based compensation expense | 0 | 1.23M | 753K | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 1.23M | 753K | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 2.08M | -1.24M | 1.09M | 2.45M | -4.45M | 1.71M |
Cash generated by operating activities | -96.23M | -10.95M | -32.97M | -94.33M | -91.35M | 6.47M |
Investing activities | ||||||
Purchases Of Investments | -73.24M | -157.46M | -97.39M | -19.99M | -286.39M | -79.56M |
Investments In Property Plant And Equipment | -228K | -2.48M | -157K | -3.73M | -21.83M | -1.95M |
Acquisitions Net | 554K | 130M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 101.32M | -2.46M | -157K | 204.89M | -51.79M | -81.52M |
Financing activities | ||||||
Common Stock Issued | 184K | 69K | 115K | 53.09M | 158.21M | 115.24M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | -17.47K |
Repayments of term debt | 0 | 30M | 0 | 0 | 0 | 0 |
Cash used in financing activities | 184K | 30.06M | 20.10M | 53.09M | 158.21M | 115.22M |
Net Change In Cash | 5.28M | 16.64M | -12.94M | 163.65M | 15.55M | 40.18M |
Cash at end of period | 39.26M | 49.54M | 32.98M | 217.43M | 53.77M | 51.57M |